| Literature DB >> 35464783 |
Siddhant Chaturvedi1,2, Shahirina Khan1,3, Rupam Kumar Bhunia1, Karambir Kaur1, Siddharth Tiwari1.
Abstract
Ascorbic acid (AsA) also known as vitamin C is considered as an essential micronutrient in the diet of humans. The human body is unable to synthesize AsA, thus solely dependent on exogenous sources to accomplish the nutritional requirement. AsA plays a crucial role in different physiological aspects of human health like bone formation, iron absorption, maintenance and development of connective tissues, conversion of cholesterol to bile acid and production of serotonin. It carries antioxidant properties and is involved in curing various clinical disorders such as scurvy, viral infection, neurodegenerative diseases, cardiovascular diseases, anemia, and diabetes. It also plays a significant role in COVID-19 prevention and recovery by improving the oxygen index and enhancing the production of natural killer cells and T-lymphocytes. In plants, AsA plays important role in floral induction, seed germination, senescence, ROS regulation and photosynthesis. AsA is an essential counterpart of the antioxidant system and helps to defend the plants against abiotic and biotic stresses. Surprisingly, the deficiencies of AsA are spreading in both developed and developing countries. The amount of AsA in the major food crops such as wheat, rice, maize, and other raw natural plant foods is inadequate to fulfill its dietary requirements. Hence, the biofortification of AsA in staple crops would be feasible and cost-effective means of delivering AsA to populations that may have limited access to diverse diets and other interventions. In this review, we endeavor to provide information on the role of AsA in plants and human health, and also perused various biotechnological and agronomical approaches for elevating AsA content in food crops. © Prof. H.S. Srivastava Foundation for Science and Society 2022.Entities:
Keywords: Antioxidant; Ascorbic acid; COVID-19; GDP-L-galactose phosphorylase Smirnoff-Wheeler pathway; Stress; Vitamin C
Year: 2022 PMID: 35464783 PMCID: PMC9016690 DOI: 10.1007/s12298-022-01172-w
Source DB: PubMed Journal: Physiol Mol Biol Plants ISSN: 0974-0430
Fig. 1Representation of major crop production in the year 2020 in the world followed by their AsA content (mg/100 g fresh weight (F.W.). 1a) Production (metric tons) status of major staple food crops viz., maize, wheat, and rice along with other crops. 1b) Food crops showing the AsA content. Staple crops (maize, wheat rice) showed the lesser amount of AsA, while the highest amount of AsA was shown in spinach followed by lemon and kiwi. The data of major crop production
adapted from the food and agriculture organization (FAO 2020, http://www.fao.org/faostat/en/#data/QC/visualize) and AsA content taken from the USDA (https://www.nal.usda.gov/) composition database
Fig. 2Pictorial representation of four different pathways for L-ascorbate biosynthesis in plants. These are the L-galactose or Smirnoff-wheeler (SW) pathway, L-gulose pathway, D-glucuronic pathway/ MIOX pathway and D-galacturonic pathway
Role of AsA and their mode of actions in various diseases
| S. No | Concentration of AsA | AsA role in disease | Mode of actions of AsA on diseases | References |
|---|---|---|---|---|
| 1 | 41–66 µmol/L | Cardiac disease | Prevents the low-density lipoproteins (LDL-proteins) from oxidative changes, prevention of ischemia/reperfusion and myocardial injury ameliorated the toxicity of the heavy metals | He et al. ( |
| 2 | 200 to 400 mg/kg | Alzheimer's disease | Reduced the depletion of dopamine and serotonin metabolites in cortex and striatum | Harrison ( |
| 3 | 150 mg/day | Prostate cancer | Inhibit the angiogenesis and increase the cytotoxicity in naïve human prostate cancer cell lines | Bai et al. ( |
| 4 | 75 g to 125 g | Pancreatic cancer | Increased the Bax/Bcl-2 expression, ROS production, DNA fragmentation and cytotoxicity of cells | Drisko et al. ( |
| 5 | 100 µg/ml | Cervical cancer | Increased the susceptibility of cisplatin and doxorubicin drug on HeLa cells and increase the level of apoptotic protein, catalase, superoxide dismutase and endoplasmic reticulum induced p-eIF2/eif2-a ratio | Shenoy et al. (2018b) |
| 6 | 50, 100 and 200 µM | Breast cancer | Induced the autophagosome by regulation of mammalian target of rapamycin (mTOR), Beclin1 and autophagy-related genes, accumulation of p62 protein, increased endoplasmic reticulum stress via IRE-JNK-CHOP signalling pathways | Bos ( |
| 7 | 0.5 mM, 2.5 mM, and 5 mM | Parkinson disease | Decreases the level of α-synuclein-Cu2 + and accumulation of Lewy bodies | da Costa Daniele et al. ( |
| 8 | 100 mg/kg to 4 g/kg | Colon cancer | Increases the cytotoxic effects of CD8 T cells, check the tumour growth by immune checkpoint therapy | Magrì et al. ( |
Fig. 3During the severe COVID-19 infection, patients experienced cytokine storm [IL-6, IL-7, IL-10, Tumor necrosis factor (TNF α), C Reactive Protein (CRP), granulocyte-colony stimulating factor (GCSF), interferon gamma-induced protein-10 (CXCL10)] and ROS production. A high levels of cytokines storms and ROS production led to inflammation that eventually turn into ARDS and sepsis. These responses induce coagulation and vessel constrictions that cause multi-organ failure. AsA scavenges the free radicles and prevents mitochondria from oxidative stress. It also inhibits the activation of NF-kB thus reducing the pro-inflammatory mediator. Thus, AsA diminishes ROS and cytokines levels and reduces the severity of the disease
Worldwide various ongoing Covid-19 clinical trials with ascorbic acid (adapted and
modified from https://clinicaltrials.gov/api/gui)
| S. No | Experiment Id | Study Objective | Status of experiment | Drugs and dietary supplements | Amount of drugs given/day | Probable outcome | Location |
|---|---|---|---|---|---|---|---|
| 1 | NCT04401150 | Effect of AsA on pneumonia caused by COVID-19 | Phase 3 | AsA | Intravenously ( 50 mg) at every 6 h | Reduction in the mortality rate and PCR levels | Research Center of the CHUS, Sherbrook, Quebec, Canada |
| 2 | NCT04558424 | Effect of AsA on symptoms (cough, fever, Headache, loss of taste and smell, Nausea, Vomiting and diarrhoea) reduction time frame | Phase 1 | Zinc gluconate and AsA | Orally, AsA (1gm) along with Zinc (220 mg) | Reduce the time of symptoms | Bangabandhu Sheikh Mujib Medical University Dhaka, Bangladesh |
| 3 | NCT04395768 | Effect of drug combination on the severity of COVID-19 disease | Phase 2 | Hydroxychloroquine, azithromycin, zinc citrate, AsA, vitamin D3, vitamin B12 | Intravenous, AsA (28 gm), Hydroxychloroquine (200 mg), Azithromycin (250 mg), Zinc Citrate (30 mg), Vitamin D3 (5,000 iu), Vitamin B12 (Methylcobalamin) (500 mcg) | Reduction in the mortality rate, hospital stay and requirement for ventilation | National Institute of Integrative Medicine, Australia |
| 4 | NCT04344184 | Effect of AsA on severity and hypoxemia | Phase 2 | Placebo, AsA | Intravenous, AsA (50 mg/kg) | Reduction in severity and hypoxemic condition in patients | Hunter Holmes McGuire VA Medical Center and Virginia Commonwealth University, Richmond, Richmond, Virginia, United States |
| 5 | NCT04279197 | Effect of these drugs on pulmonary fibrosis after COVID-19 infection | Phase 2 | Fuzheng huayu tablet, AsA, placebo, | Fuzheng Huayu Tablet (4.8 g), AsA (600 mg) | Faster improvement in pulmonary fibrosis | Shuguang Hospital Shanghai, Shanghai, China |